Related Experiment Videos
Fatal Kawasaki disease caused by early occlusive coronary artery disease
Archives of Disease in Childhood
|July 26, 2002
Insights
Severe coronary artery narrowing can occur early in Kawasaki disease, even with gammaglobulin treatment. This vaso-occlusive disease may be undetectable until it is very advanced.
Area of Science:
- Pediatric Cardiology
- Rheumatology
- Immunology
Background:
- Kawasaki disease is a leading cause of acquired heart disease in children.
- Early diagnosis and treatment are crucial to prevent coronary artery abnormalities.
- Gammaglobulin therapy is the standard treatment to reduce inflammation.
Observation:
- Severe coronary artery narrowing can manifest early in Kawasaki disease.
- This narrowing can occur despite standard gammaglobulin treatment.
- Aneurysm formation or thrombosis may not be prominent features initially.
Findings:
- Vaso-occlusive disease in Kawasaki disease may not be clinically apparent until it reaches a severe stage.
- Echocardiography might not reveal subtle or early-stage vaso-occlusive changes.
- Coronary artery narrowing can progress significantly before detection.
Implications:
- There is a need for heightened vigilance for coronary artery complications in Kawasaki disease, irrespective of initial treatment response.
- Advanced imaging or monitoring techniques may be required for early detection of vaso-occlusive disease.
- Understanding the early pathophysiology of coronary narrowing is vital for improved therapeutic strategies.
Abstract:
In Kawasaki disease severe coronary artery narrowing may develop at an early stage despite treatment with gammaglobulin and in the absence of prominent aneurysm formation or thrombosis. Vaso-occlusive disease may not be clinically or echocardiographically apparent until very severe.